Tse Brian W C, Scott Kieran F, Russell Pamela J
Australian Prostate Cancer Research Centre-Queensland, Queensland University of Technology, Brisbane, QLD 4102, Australia ; Institute of Health and Biomedical Innovation, Cells and Tissue Domain, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Prostate Cancer. 2012;2012:128965. doi: 10.1155/2012/128965. Epub 2012 Dec 27.
Tumour necrosis factor (TNF) is a pleiotropic cytokine with dual roles in cancer biology including prostate cancer (PCa). On the one hand, there is evidence that it stimulates tumour angiogenesis, is involved in the initiation of PCa from an androgen-dependent to a castrate resistant state, plays a role in epithelial to mesenchymal plasticity, and may contribute to the aberrant regulation of eicosanoid pathways. On the other hand, TNF has also been reported to inhibit neovascularisation, induce apoptosis of PCa cells, and stimulate antitumour immunity. Much of the confusion surrounding its seemingly paradoxical roles in cancer biology stems from the dependence of its effects on the biological model within which TNF is investigated. This paper will address some of these issues and also discuss the therapeutic implications.
肿瘤坏死因子(TNF)是一种多效性细胞因子,在包括前列腺癌(PCa)在内的癌症生物学中具有双重作用。一方面,有证据表明它能刺激肿瘤血管生成,参与前列腺癌从雄激素依赖状态向去势抵抗状态的转变,在上皮-间质可塑性中发挥作用,并可能导致类花生酸途径的异常调节。另一方面,也有报道称TNF可抑制新血管形成,诱导前列腺癌细胞凋亡,并刺激抗肿瘤免疫。围绕其在癌症生物学中看似矛盾的作用产生的许多困惑,源于其效应依赖于研究TNF的生物学模型。本文将探讨其中的一些问题,并讨论其治疗意义。